These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 8082724)
1. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells. Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724 [TBL] [Abstract][Full Text] [Related]
2. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Wu SP; Sun LZ; Willson JK; Humphrey L; Kerbel R; Brattain MG Cell Growth Differ; 1993 Feb; 4(2):115-23. PubMed ID: 8494782 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation. Hafez MM; Infante D; Winawer S; Friedman E Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877 [TBL] [Abstract][Full Text] [Related]
4. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells. Periyasamy S; Sun L; Gentry LE; Brattain MG J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926 [TBL] [Abstract][Full Text] [Related]
5. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor. Jiang D; Liang J; Humphrey LE; Yang H; Brattain MG J Cell Physiol; 1998 May; 175(2):174-83. PubMed ID: 9525476 [TBL] [Abstract][Full Text] [Related]
6. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532 [TBL] [Abstract][Full Text] [Related]
7. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta. Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169 [TBL] [Abstract][Full Text] [Related]
9. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
10. Differential regulation of c-myc and transforming growth factor-alpha messenger RNA expression in poorly differentiated and well-differentiated colon carcinoma cells during the establishment of a quiescent state. Mulder KM Cancer Res; 1991 May; 51(9):2256-62. PubMed ID: 2015589 [TBL] [Abstract][Full Text] [Related]
12. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cohen PS; Letterio JJ; Gaetano C; Chan J; Matsumoto K; Sporn MB; Thiele CJ Cancer Res; 1995 Jun; 55(11):2380-6. PubMed ID: 7757990 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells. Zipfel PA; Ziober BL; Morris SL; Mulder KM Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591 [TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells. Koli K; Keski-Oja J Cancer Res; 1995 Apr; 55(7):1540-6. PubMed ID: 7882362 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2. Joyce NC; Harris DL; Mello DM Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3). Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346 [TBL] [Abstract][Full Text] [Related]